{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:56:51Z","timestamp":1779253011797,"version":"3.51.4"},"reference-count":0,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"vor","delay-in-days":2314,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:p><jats:italic>Aims<\/jats:italic>\u2007Hyoscine (scopolamine), which is effective in the prophylaxis of motion sickness, shows similar binding affinities to all of the five known muscarinic receptor sub\u2010types. The effectiveness of hyoscine was compared with zamifenacin (UK\u201076654), which binds selectively to the muscarinic M<jats:sub>3<\/jats:sub> and m5 receptors.<\/jats:p><jats:p><jats:italic>Methods<\/jats:italic>\u2007Eighteen subjects received hyoscine hydrobromide 0.6\u2003mg, zamifenacin 20\u2003mg, or placebo (double\u2010blind cross\u2010over design). Sessions were 1 week apart and the drug (oral) was given 90\u2003min prior to a motion sickness test. Motion sickness was elicited by cross\u2010coupled stimulation on a turntable. The rotational velocity was incremented by 2\u00b0\u2003s<jats:sup>\u22121<\/jats:sup> every 30\u2003s, and a sequence (seq) of eight head movements of 45\u00b0 was completed every 30 s. Motion tolerance was assessed as the number of sequences of head movement required to achieve moderate nausea. Pulse rate was recorded before and at 1 and 2\u2003h after drug administration. Skin conductance activity in the frequency band 0.005\u20130.48\u2003Hz, an index of sweat gland activity, was measured using Ag\/AgCl electrodes on the palmar surfaces of fingers and across the forehead.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>\u2007Both zamifenacin and hyoscine produced an increase in tolerance to the motion challenge (<jats:italic>P<\/jats:italic>&lt;0.01) with no significant difference between the two drugs (5.0\u00b11.6 <jats:italic>vs<\/jats:italic> 5.7\u00b11.6 seqs. respectively, mean\u00b1s.e.mean). Compared with placebo or zamifenacin, pulse rate fell following hyoscine administration (9 beats\u2003min<jats:sup>\u22121<\/jats:sup>, <jats:italic>P<\/jats:italic>&lt;0.01). Skin conductance was reduced following hyoscine compared with zamifenacin or placebo (<jats:italic>P<\/jats:italic>&lt;0.001).<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>\u2007These results suggest that compounds with selective M<jats:sub>3<\/jats:sub> and\/or m5 antagonism possess activity against motion sickness. Antagonism at these receptors may be the basis of the anti\u2010motion sickness action of hyoscine.<\/jats:p>","DOI":"10.1046\/j.1365-2125.1997.00606.x","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T17:01:11Z","timestamp":1066150871000},"page":"633-637","source":"Crossref","is-referenced-by-count":79,"title":["Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate"],"prefix":"10.1111","volume":"43","author":[{"given":"J. F.","family":"Golding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R. R.","family":"Stott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,2]]},"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1997.00606.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1997.00606.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1997.00606.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T07:20:17Z","timestamp":1698391217000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2125.1997.00606.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["10.1046\/j.1365-2125.1997.00606.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2125.1997.00606.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}